Lloyd Diamond

Chief Executive Officer @Nitinotes which is preparing for the launch of its EndoZip automated endoscopic suturing system for the treatment of obesity.

[Lloyd Diamond @tmcdiamond]

EndoZip™ is CE marked and approved for commercial use in Europe. In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Lloyd Diamond @tmcdiamond]

I'm proud to share that the first commercial EndoZip™ procedures in France have been performed at IHU Strasbourg, with Prof. Silvana Perretta.

[Lloyd Diamond @tmcdiamond]

Read the full announcement: https://t.co/Ex9tNL08Ag

#EndoZip #ESG #France #BariatricEndoscopy #ObesityCare

[Lloyd Diamond @tmcdiamond]

EndoZip™ is CE marked and approved for commercial use in Europe. In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use. Statements regarding ESG are based on published clinical literature.

[Lloyd Diamond @tmcdiamond]

I had the opportunity to take part in the 2nd Annual Obesity & Cardiometabolic Innovation Forum.

[Lloyd Diamond @tmcdiamond]

Thank you to the Sachs team for the invitation and to everyone who joined the conversation.
#Sachs_OCIF #ObesityCare #ESG

[Lloyd Diamond @tmcdiamond]

EndoZip™ is CE marked and approved for commercial use in Europe. In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Lloyd Diamond @tmcdiamond]

Wrapping up Endolive Roma 2026.

Three days of live video demonstrations and lectures across diagnostic and therapeutic GI endoscopy, with bariatric and metabolic endoscopy taking its place within the broader live program.

[Lloyd Diamond @tmcdiamond]

Thank you to the colleagues who stopped by, and to the endoscopy community in Rome for the live discussions.

#Endolive2026 #BariatricEndoscopy #ESG

[Lloyd Diamond @tmcdiamond]

Thank you to the forum organizers for the invitation. 
Excited to join the discussion with this excellent group of panelists and colleagues.

📅 June 5, 2026 - afternoon session 
📍 Royal Sonesta- New Orleans

If you're attending, I look forward to connecting.

[Lloyd Diamond @tmcdiamond]

Looking forward to attending the 2nd Annual Obesity & Cardiometabolic Innovation Forum and joining the panel "Personalized Approaches: Precision & Combination Therapies".

[Lloyd Diamond @tmcdiamond]

I'm looking forward to discussing how precision and combination approaches are shaping the next chapter of obesity and cardiometabolic care.